See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Pfizer Inc. (PFE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pfizer Inc. (PFE) - free report >>
Image: Bigstock
Gaming ETF (BJK) Hits a New 52-Week High
For investors seeking momentum, VanEck Vectors Gaming ETF (BJK - Free Report) is probably on radar. The fund just hit a 52-week high, and is up about 130% from its 52-week low price of $20.02/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BJK in Focus
This fund provides investors with exposure to companies involved in casinos and casino hotels, sports betting, lottery services, gaming services, gaming technology and gaming equipment. The fund charges investors 66 basis points a year in fees (see: all the Consumer Discretionary ETFs here).
Why the Move?
The gaming corner of the broad stock market has been an area to watch lately given the historic development to counter the worst pandemic in over 100 years. The United States has geared up for the largest-ever immunization with the rollout of the COVID-19 vaccine developed by Pfizer (PFE - Free Report) in collaboration with BioNTech (BNTX - Free Report) to millions of Americans. A vaccine has set the stage for speedy recovery thereby boosting demand for several types of products and services in the economy, which were otherwise beaten down badly due to the pandemic.
More Gains Ahead?
Currently, BJK has a Zacks ETF Rank #3 (Hold) with a High risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>